Myant Corp. Acquires Nanoleq and Osmotex Technologies

Myant Corp. Acquires mmHg Inc.

January 6, 2025

Healthcare Services

Myant Corp., a textile-computing and connected-health company based in Canada, has acquired mmHg Inc., a physician-led digital health firm specializing in remote blood pressure monitoring and cardiovascular risk management. The acquisition adds clinical-grade remote monitoring and cardiovascular analytics to Myant's offerings and expands Myant's market reach into the United States through mmHg's existing customer relationships and device partnerships.

Fabric Acquires GYANT

January 31, 2024

AI & Machine Learning

Fabric, a care enablement platform founded by Aniq Rahman, has acquired conversational AI company GYANT in an all-cash deal and brought the entire GYANT team into Fabric. The acquisition expands Fabric’s product capabilities in conversational patient engagement and increases its employee base (Fabric expanded to ~130 employees) while adding GYANT co-founder Stefan Behrens to Fabric’s executive team as chief strategy officer.

Myant Acquires Bitnobi Inc.

January 17, 2025

Data & Analytics

Myant has acquired Toronto-based Bitnobi Inc., a startup that provides privacy‑protected data‑sharing software, to integrate secure data collaboration capabilities into Myant's connected‑health platform. The deal—Myant's fourth strategic acquisition in six months—aims to strengthen the company's precision‑health roadmap by enabling safe data sharing with researchers, clinicians and third parties.

Lantheus Acquires Meilleur Technologies (NAV-4694)

July 15, 2024

Pharmaceuticals

Lantheus Holdings, Inc. announced the acquisition of Meilleur Technologies, Inc., giving Lantheus worldwide exclusive rights to NAV-4694 (F18-flutafuranol), a Phase 3 ß-amyloid PET imaging agent for Alzheimer’s disease. The deal includes an upfront payment plus potential development/commercial milestones and royalties, and the sellers will provide transition and clinical development services following closing.

Medtronic Acquires Nano Surface Technology Assets from Nanovis

February 12, 2025

Medical Devices

Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.

Shoei Chemical Acquires Quantum Dot Business from Nanosys

September 7, 2023

Manufacturing

Shoei Chemical, together with its North American subsidiary Shoei Electronic Materials, completed an asset purchase agreement to acquire substantially all assets of Nanosys' quantum dot business, including its sales and marketing teams, R&D team, and Silicon Valley laboratories. The deal brings Nanosys' quantum dot technology and IP under Shoei to strengthen Shoei's advanced materials and display-materials capabilities while retaining the Nanosys brand and operations in the U.S.